Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKesson
UBS
Covington
Cipla
QuintilesIMS
US Army
Express Scripts
Farmers Insurance
Chinese Patent Office

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021704

« Back to Dashboard

NDA 021704 describes ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from three suppliers. There are two patents protecting this drug. Additional details are available on the ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION profile page.

The generic ingredient in ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION is fexofenadine hydrochloride; pseudoephedrine hydrochloride. There are twenty-three drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride; pseudoephedrine hydrochloride profile page.
Summary for 021704
Pharmacology for NDA: 021704
Suppliers and Packaging for NDA: 021704
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION fexofenadine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 021704 NDA sanofi-aventis U.S. LLC 0088-1095 E 0088-1095-47
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION fexofenadine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 021704 NDA Chattem, Inc. 41167-4320 N 41167-4320-3

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TABLET, EXTENDED RELEASE;ORALStrength180MG;240MG
Approval Date:Jan 24, 2011TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Dec 25, 2020Product Flag?YSubstance Flag?Delist Request?
Patented Use:RELIEF OF SYMPTOMS ASSOCIATED WITH RESPIRATORY ALLERGIES, SWELLING OF THE NASAL PASSAGES AND SINUS CONGESTION AND PRESSURE IN ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER
Patent:➤ Try a Free TrialPatent Expiration:May 29, 2018Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 021704

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Federal Trade Commission
Medtronic
US Army
Baxter
AstraZeneca
Teva
Citi
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot